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1. Introduction 
The total copper content of biofluids uch as 
blood plasma is composed of three fractions: 
(i) Inert metalloproteins (95% of Cu in blood). 
(ii) Exchangeable protein copper complexes (5%). 
(iii) Low molecular weight (low mol. wt) copper 
complexes (< 1%). 
It has been clearly established that it is the minority 
low mol. wt complexes which are responsible for the 
excretion and for the distribution of the metal ions 
into body tissue [1,2]. 
Computer models of the distribution of metal-ions 
amongst complexes inblood plasma have been 
published [3-5]. Essentially these are equilibrium 
calculations based upon stability constants and the 
respective metal and ligand concentrations. These 
models have enabled us to explain and to predict he 
action of different agents used in chelation therapy. 
Also they have made it clear that chelation from 
serum albumin is not the 'modus operandi' through 
which D-penicillamine liberates copper(II) into low 
mol. wt form [5]. The apparent inability of this 
agent o procure albumin-bound copper cannot be 
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correlated with the substantial cupruresis nduced 
when this drug is administered topatients [6], This 
had led us to investigate the possible mechanisms of
activity of chelating agents and in particular the 
influence of D-penicillamine upon ceruloplasmin i  
saline solution and in blood plasma. Although cerulo- 
plasmin represents he major portion of copper in 
plasma the metal is inertly bound and is not normally 
available to the labile equilibrium system [7]. Hence 
any small iberation of copper from ceruloplasmin 
(e.g. 1%) will produce alarge increase in the labile 
copper fraction (in the e.g., up to a 20% increase). 
Much research as been reported concerning the 
amount and availability of copper in ceruloplasmin 
[8-11]. The review [7] concludes that ceruloplasmin 
contains 8 copper atoms, 4 of which are exchangeable 
when reduced. At low pH all the copper atoms can be 
reversibly removed [ 12]. More recent work has tended 
to suggest that there are only 6 tightly held copper 
atoms per ceruloplasmin molecule and possibly one 
exchangeable copper atom [ 13]. The underlying 
reasons for these dichotomies are the uncertainty in
the tool. wt (132 000-150 000) of the protein and 
the ease with which it is degraded [ 13,14]. Thus we 
have chosen experimental methods which are indepen- 
dent of these two factors. 
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2. Materials and methods 
Three copper-containing protein solutions, human 
serum, plasma nd a pure ceruloplasmin solution, 
were treated with chelating agents and the resulting 
low mol. wt species eparated by ultrat~titration. 
Copper concentrations i  each fraction were then 
determined by atomic absorption spectrophotometry 
and colorimetric analysis. 
2.1. Chemicals 
Ethylenediaminetetraacetic acid (EDTA) triethyl- 
enetetramine (Trien) and ascorbic acid (Asc) were 
obtained from BDH Biochemicals, diethylenetri- 
aminepentaacetic acid (DTPA) from R. N. Emanuel 
Ltd, sodium diethyldithiocarbamate (DDC) from 
Fisons Ltd and D-penicillamine (D-Pen) from Koch- 
Light Labs, human serum and plasma (citrated) from 
Ninewells Hospital, Dundee, and ceruloplasmin solu- 
tion from Serva Fein Biochemica. 
2.2. Ultrafiltration and atomic absorption 
To pooled human serum or plasma (10 ml samples) 
chelating agents were added (to final conc. 
25 mmol.dm -a) and the solution left to stand for 
1 h, then filtered with stirring (Millipore f'tltration 
apparatus type XX4202510, 25 mm) using filters 
having a nominal mol. wt cut-off of 25 000 (Millipore 
PTGC 025J0) and an overpressure of25 psi of 
nitrogen, giving a filtration rate of 2 ml/h. The same 
volume of ftitrate was collected in each investigation 
(2 ml) and analysed for total copper content (Perkin- 
Elmer 360 atomic absorption spectrophotometer with 
digital read-out and deuterium background corrector). 
Standard copper solutions for these analyses were 
prepared in 10% glycerol [15]. Ceruloplasmin solu- 
tions (5%)were diluted 100-fold with phosphate 
buffer at pH 7.4. A background concentration f
150 mmol.dm -3 NaCI was used in the preparation of 
the ceruloplasmin and the chelating agent solutions. 
The results of the copper analyses are listed in table 1. 
They are accurate to better than 5% with the excep- 
tion of Trien (25 mmol.dm -3) which is better than 
10%. 
2.3. Spectrophotometric determinations 
Exchangeable copper in serum and ceruloplasmin 
solutions was determined by complexation with DDC 
and spectrophotometric analysis [16]. A Unicam 
SP800B instrument was used. In general the results 
are in agreement with those determined by atomic 
absorption. However, the concentrations in question 
are near to the limits of detectability by spectral 
approaches and so atomic absorption is considered 
to be the much more reliable method. The commer- 
cially supplied ceruloplasmin solutions were found to 
contain a large amount of exchangeable copper. DDC 
had previously been used to extract total ceruloplasmin 
copper at low pH [ 12] but to remove solely exchange- 
able copper at higher pH [ 16]. Since we were working 
at pH 7.4 it must be concluded that the ceruloplasmin 
solutions upplied had suffered considerable degrada- 
tion during or since their manufacture [ 13 ]. 
3. Results and discussion 
The ability of the series of agents used in this 
study to mobilize the copper of blood plasma, serum 
and ceruloplasmin solutions into a low mol. wt form 
is shown in table 1. Since the ultraftitrable component 
may be raised substantially above the 5% of the total 
copper corresponding to the albumin-bound fraction 
in blood plasma nd serum, it can be concluded that 
in these cases the additional copper at least is derived 
from ceruloplasmin. This is supported by the similari- 
ty in percentage copper mobilized in all three fluids 
investigated. 
The effects of the agents roughly parallel their 
copper binding ability, i.e.: 
Trien > DTPA > EDTA > D-Pen, DDC, Asc 
This suggests that chelation is an important step in 
the irreversible degradation of the metalloprotein. 
Our results are in agreement with the copper mobiliz- 
ing order [8] ; for ceruloplasmin solutions at lower 
pH they found EDTA>>D-Pen. We also noted the 
increased mobilization of copper from plasma under 
a nitrogen atmosphere which they obtained from 
ceruloplasmin solution although the possibility that 
D-Pen liberates ceruloplasmin copper simply by 
reduction isnegated by comparing the D-Pen and Asc 
results. 
Figure 1 indicates that a kinetic factor is involved 
when Trien removes copper from ceruloplasmin; this 
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Table 1 
Atomic absorption analyses on various ultrafiltration samples of serum, 
plasma nd ceruloplasmin solution 
Sample 
% 
100 
Copper concentrations 
Serum Plasma Ceruloplasmin 
ppm % ppm % ppm % A% 
Blanks 
Total Cu 
Filtrate 
1.05 100 0.75 100 2.18 100 - 
0.03 2.7 0.00 0.0 0.55 25.2 0.0 
Experiments 
Additions to 
protein solutions 
D-Pen 0.07 6.6 
EDTA 0.18 17.1 
Trien 0.43 41.0 
DTPA 0.32 29.1 
DDC 0.00 0.0 
D-Pen 
+ EDTA 0.50 47.6 
D-Pen 
+ Trien 0.60 57.1 
D-Pen 
+ DTPA 0.36 32.7 
D-Pen 
+ DDC 0.16 14.6 
Asc 
+ DDC 0.0 0.0 
Asc 
+ EDTA 0.14 12.7 
0.00 0.0 0.80 36.7 6.4 
0.12 16.7 0.90 41.3 11.0 
0.31 41.3 1.55 71.0 40.7 
- - 0.66 30.3 0.0 
0.27 36.7 1.00 45.9 15.6 
0.44 58.7 
1, 150 mmol dm -3 NaC1. %, % total copper a%, (% - background reading from DDC results) 
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may arise either f rom steric h indrance to the agent 
b inding the meta l loprote in  copper  or f rom a Trien- 
p romoted  chemical  degradat ion of  the ceruloplasmin. 
However, the concentrat ion  dependence of  Trien- 
l iberated copper,  shown in fig.2, is diff icult to recon- 
cile w i th  a solely kinetic phenomenon.  Rather,  it 
appears indicative of  some mechan ism involving 
chelat ion. 
Fig.1. The kinetics of copper mobilization from serum using 
Trien. The percentage of total copper in low mol. wt form 
is plotted versus the time (in min). 
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Fig.2. The effect of Trien concentration upon the degree of 
copper mobilization. The percentage of copper in low mol. wt 
form is plotted versus log (total Trien conc.). 
These studies till cannot explain the very large 
cupruresis produced by D-Pen therapy relative to 
EDTA and Trien [20]. It seems likely that whatever 
the mode of action of D-Pen, it ultimately increases 
the low mol. wt copper concentration i  plasma. This 
is in spite of its inability to degrade ceruloplasmin or
to compete ffectively with labile copper binding 
proteins in the biofluid. If this proposition is correct, 
an alternative improved treatment for Wilson's 
Disease is possible: simultaneous administration of
D-Pen and Tfien should produce a synergistic cupru- 
resis. The Trien would hold the copper labilized into 
plasma by D-Pen as a low mol. wt charged complex 
[5] thereby considerably facilitating its renal excre- 
tion. Such a therapeutic strategy is expected to lower 
the required D-Pen dosage and so minimise the side 
effects for which this drug is often responsible. 
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Our results with respect to D-Pen show that this 
agent alone causes very little increase in low mol. wt 
copper. Thus the drug is incapable of removing the 
metal from ceruloplasmin and/or is not able to main- 
tain any additional exchangeable copper in a low mol. 
wt form. The synergistic effects hown when two 
chelating agents are introduced simultaneously 
suggest that D-Pen does release asmall amount of 
copper from ceruloplasmin, transferring it to serum 
albumin in the absence of some more powerful 
chelating agent, with only a small proportional 
increase of the low mol. wt fraction [17]. These con- 
clusions are at variance with [18] where 32.3% of 
the total copper in serum was found to be ultra- 
filtrable after the addition of D-Pen. One explanation 
for this difference may lie in the type of molecular 
filters used: the collodion filters may not have been 
sufficiently discriminating and allowed serum albumin 
to pass through whereas our filters have been checked 
for this [19]. 
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